03.09.10
RepRegen, previously known as BioCeramic Therapeutics, said today that data from an in-vitro study has demonstrated that its Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in-vivo studies, which are under way, show similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard tissue, such as bone, the company said.
The in-vitro study was presented Monday in a science session during the 56th Annual Meeting of the Orthopaedic Research Society in New Orleans, La., by Matthew O’Donnell, Ph.D., research and development manager for RepRegen, which is based in London, England.
According to RepRegen, the hard-tissue platform is based on bioceramics that are designed to be used initially by orthopedic product manufacturers and surgeons.
“Replacing broken or worn-out body parts are not new ideas, of course. But our ‘smart’ biomaterials are designed to enhance the cellular growth properties of tissue and also catalyze better and faster healing,” said Molly Stevens, Ph.D., RepRegen’s chief scientific officer.
RepRegen, based in London, England, is a spin-out from the Imperial Innovations incubator at Imperial College London that uses repair and regeneration technology platforms designed to mend and regrow hard tissue such as bone and soft tissue such as cartilage.
The in-vitro study was presented Monday in a science session during the 56th Annual Meeting of the Orthopaedic Research Society in New Orleans, La., by Matthew O’Donnell, Ph.D., research and development manager for RepRegen, which is based in London, England.
“Replacing broken or worn-out body parts are not new ideas, of course. But our ‘smart’ biomaterials are designed to enhance the cellular growth properties of tissue and also catalyze better and faster healing,” said Molly Stevens, Ph.D., RepRegen’s chief scientific officer.
RepRegen, based in London, England, is a spin-out from the Imperial Innovations incubator at Imperial College London that uses repair and regeneration technology platforms designed to mend and regrow hard tissue such as bone and soft tissue such as cartilage.